| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-09 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.26 | 2e-08 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.25 | 4e-06 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-06 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.16 | 3e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.14 | 5e-05 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.23 | 6e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.21 | 7e-05 |